Evaluation of the Effectiveness of Using Virtual Reality Glasses in Prehospital Intervention Training for Crush Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
Virtual reality-based crush syndrome training: A scenario-based three-dimensional virtual reality training program focusing on prehospital crush syndrome assessment and management.
Traditional theoretical lecture: Conventional theoretical classroom instruction on prehospital crush syndrome assessment and management.
Study summary
This research is a randomized controlled study designed to develop and evaluate the effectiveness of a video-based virtual reality (VR) simulation for prehospital intervention training of crush syndrome for paramedic students. The study aims to examine the impact of VR simulation on knowledge levels, satisfaction, and sense of presence among second-year first and emergency aid students at Muğla Sıtkı Koçman University.
Eligibility
Primary outcome measure(s)
- Prehospital crush syndrome knowledge level — Baseline (pre-test) and immediately after the training session (post-test).
The knowledge level of participants is measured using the full 'prehospital crush syndrome knowledge level scale'. The scale consists of 32 items covering four sub-dimensions: general knowledge (12 items), treatment (9 items), transport (6 items), and advanced knowledge (5 items). Each correct answer is scored as 1 point, while incorrect or 'no idea' answers are scored as 0. The total score ranges from a minimum of 0 to a maximum of 32. A higher total score indicates a better understanding and a higher knowledge level of prehospital crush syndrome management.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Muğla Sıtkı Koçman University, Fethiye Health Services Vocational School | Muğla | Turkey (Türkiye) |
More Ege University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07361835 on ClinicalTrials.gov ↗ ← All trials in Turkey